홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Meclofenamic Acid

HCID 4037
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
644-62-2
표준 SMILES
Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl
InChIKey
SBDNJUWAMKYJOX-UHFFFAOYSA-N
분자식
C14H11Cl2NO2
평균 분자량
296.1 g/mol
단동위원소 질량
295.016684

개요

Meclofenamic acid is an aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. It has a role as a non-steroidal anti-inflammatory drug, an analgesic, an antipyretic, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor, an antineoplastic agent, an anticonvulsant, an antirheumatic drug and an EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor. It is an aminobenzoic acid, an organochlorine compound and a secondary amino compound. It is a conjugate acid of a meclofenamic acid(1-).

이름 및 식별자

우선 이름
Meclofenamic Acid
IUPAC
2-(2,6-dichloro-3-methylanilino)benzoic acid
영어명
Meclofenamic acid
분자식
C14H11Cl2NO2
분자량
296.15

이름 및 동의어

meclofenamic acidmeclofenamate644-62-2Arquel2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acidAcido meclofenamicoAcide meclofenamiqueINF 4668Acidum meclofenamicumN-(2,6-Dichloro-m-tolyl)anthranilic acidMeclomenCI-583
이름 더 보기
MeclofenNSC 95309MeclorfenamicmeclofenamicaciMeclofemic acidMeclophenamic acidC14804500 MeclofenamiCacid
INF-4668N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid2-((2,6-Dichloro-3-methylphenyl)amino)benzoic acidN-(2,6-Dichloro-3-methylphenyl)anthranilic acidNSC-95309Arquel Tablets48I5LU4ZWDCL-583

데이터베이스 식별자

CAS
644-62-2
PubChem CID
4037
DTXSID
DTXSID0048559
ChEMBL
CHEMBL509
ChEBI
CHEBI:6710
UNII
48I5LU4ZWD
EC Number

물성

구조 계산 물성

XLogP
5.2
극성 표면적
49.3 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
3
회전 가능 결합 수
3
무거운 원자 수
19
형식 전하
0
복잡도
327

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceutical

Pharmaceuticals -> Listed in ZINC15

LogP · 2건

5

5.9

Solubility3.66e-03 g/L
Human Drugs · 2건

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

Pharmaceuticals

Animal DrugsFDA approved animal drugs -> Active ingredient
Melting Point · 2건

248-250

257 °C

Physical DescriptionSolid
Collision Cross Section155.91 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
257 · 257-259°C
끓는 점
399.4 · 399.4±42.0 °C(Predicted)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6건

Meclofenamate

4.7

19.7

The recommended dose is 50 mg every 4 to 6 hours.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 200 mg/day, Lowest Therapeutic Dose (LTD): 2.5 mg/kg-day, and Screening Dose: 0.0008 mg/kg-day.

15-May-21

화학 및 산업

약리 정보

ATC Code · 4건

M - Musculo-skeletal system

M - Musculo-skeletal system

QM - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingGreater than 99% bound to plasma proteins over a wide drug concentration range.
PharmacodynamicsMeclofenamic acid is a nonsteroidal agent which has demonstrated anti-inflammatory, analgesic, and antipyretic activity in laboratory animals.
Mechanism of Action · 1건

The mode of action, like that of other nonsteroidal anti-inflammatory agents, is not known. Therapeutic action does not result from pituitary-adrenal stimulation. In animal studies, meclofenamic acid was found to inhibit prostaglandin synthesis and to compete for binding at the prostaglandin receptor site. In vitro meclofenamic acid was found to be an inhibitor of human leukocyte 5-lipoxygenase activity. These properties may be responsible for the anti-inflammatory action of meclofenamic acid. There is no evidence that meclofenamic acid alters the course of the underlying disease.

Biological Half-LifeIn a study in 10 healthy subjects following a single oral dose the apparent elimination half-life ranged from 0.8 to 5.3 hours. Metabolite I (3-hydroxymethyl metabolite of meclofenamic acid) has a mean half-life of approximately 15 hours.
Metabolism/Metabolites · 1건

Hepatic. Meclofenamic acid is extensively metabolized to an active metabolite (Metabolite I; 3-hydroxymethyl metabolite of meclofenamic acid) and at least six other less well characterized minor metabolites. Only Metabolite I has been shown in vitro to inhibit cyclooxygenase activity with approximately one fifth the activity of meclofenamic acid.

MeSH Pharmacological Classification · 2건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

관련 반응

10건
반응 기록 만들기
HRID 343884 반응식
HRID 343884반응물로
HRID 703206 반응식
HRID 703206반응물로
HRID 703216 반응식
HRID 703216반응물로
HRID 973955 반응식
HRID 973955반응물로
HRID 1088290 반응식
HRID 1088290반응물로
HRID 1195871 반응식
HRID 1195871반응물로
HRID 1461424 반응식
HRID 1461424반응물로
HRID 1461433 반응식
HRID 1461433반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
211-419-5
Nikkaji
J7.065C
밀도
1.3567 · 1.3567 (rough estimate)
굴절률
1.607 · 1.6070 (estimate)
저장 조건
Refrigerator
용해도
클로로포름(약간 용해됨), 메탄올(약간 용해됨, 가열)
물리적 상태
고체
산도 계수 (pKa)
4 · pKa 4.0 (Uncertain)
색상
미색에서 밝은 오렌지색까지
EPA
2 · Benzoic acid, 2-[(2,6-dichloro-3-methylphenyl)amino]- (644-62-2)

화학적 성질

White Crystalline Solid

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

Absorption, Distribution and Excretion · 4건

Rapidly absorbed in man following single and multiple oral doses with peak plasma concentrations occurring in 0.5 to 2 hours. The concomitant administration of antacids (aluminum and magnesium hydroxides) does not interfere with absorption of meclofenamic acid. Unlike most NSAIDs, which when administered with food have a decrease in rate but not in extent of absorption, meclofenamic acid is decreased in both. It has been reported that following the administration of meclofenamic acid capsules one-half hour after a meal, the average extent of bioavailability decreased by 26%, the average peak concentration (Cmax) decreased fourfold and the time to Cmax was delayed by 3 hours.

Other metabolites, whose excretion rates are unknown, account for the remaining 35% to 62% of the dose excreted in the urine. The remainder of the administered dose (approximately 30%) is eliminated in the feces (apparently through biliary excretion). Trace amounts of meclofenamate sodium are excreted in human breast milk.

9.1 to 43.2 L

Oral cl=206 mL/min

Cellular LocationsCytoplasm

용도 및 제조

Use ClassificationPharmaceuticals

응용 분야

용도Meclofenamic acid is used for the same conditions as flufenamic acid.

상·하류 제품 정보

상류 원료

4-Chloro-3-nitrotoluene2-클로로벤조익산에틸모르폴린2,6-디클로로-3-메틸아닐린
추가 설명 · 1건

정의ChEBI: An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoe (painful periods), osteoarthritis and rheumatoid arthritis.